Mayport LLC’s AbbVie ABBV Stock Holding History

Mayport LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Buy	7,269 +111	+2%	+$24.6K	0.29%	39
2025 Q4	$1.64M	Sell	7,158 -92	-1%	-$21K	0.33%	34
2025 Q3	$1.68M	Buy	7,250 +129	+2%	+$26.3K	0.36%	30
2025 Q2	$1.32M	Sell	7,121 -13	-0.2%	-$2.42K	0.32%	34
2025 Q1	$1.49M	Buy	7,134 +581	+9%	+$113K	0.41%	28
2024 Q4	$1.16M	Sell	6,553 -120	-2%	-$22.1K	0.34%	35
2024 Q3	$1.32M	Buy	6,673 +376	+6%	+$70.2K	0.42%	31
2024 Q2	$1.08M	Buy	6,297 +1	+0%	+$166	0.38%	35
2024 Q1	$1.15M	Sell	6,296 -2,568	-29%	-$443K	0.44%	34
2023 Q4	$1.37M	Buy	8,864 +27	+0.3%	+$3.94K	0.62%	27
2023 Q3	$1.32M	Buy	8,837 +3,575	+68%	+$525K	0.72%	24
2023 Q2	$709K	Hold	5,262	–	–	0.4%	31
2023 Q1	$839K	Hold	5,262	–	–	0.52%	29
2022 Q4	$850K	Sell	5,262 -93	-2%	-$14.3K	0.64%	28
2022 Q3	$719K	Sell	5,355 -65	-1%	-$9.33K	0.59%	28
2022 Q2	$830K	Buy	5,420 +404	+8%	+$61.7K	0.68%	25
2022 Q1	$813K	Sell	5,016 -2,595	-34%	-$377K	0.56%	26
2021 Q4	$1.03M	Buy	+7,611	New	+$899K	0.77%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mayport LLC's ABBV Position: Q1 2026 in Review

Mayport LLC increased its AbbVie (ABBV) stake by 1.6% in Q1 2026, buying an estimated $24.6K and bringing the position to 7,269 shares worth $1.58M. The position accounts for 0.29% of the portfolio, ranked #39.

Mayport LLC first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.68M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Mayport LLC held 7,269 shares of AbbVie worth $1.58M as of Q1 2026.
Mayport LLC bought 111 AbbVie shares in Q1 2026, an estimated $24.6K.
AbbVie made up 0.29% of Mayport LLC's portfolio in Q1 2026, its #39 holding.
Mayport LLC first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Mayport LLC's AbbVie position peaked at $1.68M in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mayport LLC's 13F filing for Q1 2026, filed 21 Apr 2026.